
BB Biotech Investor Relations Material
Latest events

Q1 2025
25 Apr, 2025

Q4 2024
21 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BB Biotech AG
Access all reports
BB Biotech AG is an investment company specializing in biotechnology. The company focuses on building a diversified portfolio of publicly listed biotech companies, primarily in the fields of drug development and medical research. BB Biotech's investments target companies involved in innovative treatments for diseases across therapeutic areas such as oncology, rare diseases, and infectious diseases. The company is headquartered in Schaffhausen, Switzerland, and its shares are listed on the SIX.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
BION
Country
🇨🇭 Switzerland